A E Ross
Overview
Explore the profile of A E Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutera P, Shetty A, Hakansson A, Van der Eecken K, Song Y, Liu Y, et al.
Ann Oncol
. 2023 May;
34(7):605-614.
PMID: 37164128
Background: Metastatic castration-sensitive prostate cancer (mCSPC) is commonly classified into high- and low-volume subgroups which have demonstrated differential biology, prognosis, and response to therapy. Timing of metastasis has similarly demonstrated...
2.
Ross A, McCulloch D, McKenzie D
Acta Crystallogr A Found Adv
. 2020 Jul;
76(Pt 4):468-473.
PMID: 32608362
The Debye scattering equation is now over 100 years old and has been widely used to interpret diffraction patterns from randomly oriented groups of atoms. The present work develops and...
3.
Reyes D, Rowe S, Schaeffer E, Allaf M, Ross A, Pavlovich C, et al.
Med Oncol
. 2020 Jun;
37(7):60.
PMID: 32524295
To evaluate the outcomes of total eradication therapy (TET), designed to eradicate all sites of visible cancer and micrometastases, in men with newly diagnosed oligometastatic prostate cancer (OMPCa). Men with...
4.
Ross A, Pompano R
Anal Chim Acta
. 2018 Jan;
1000:205-213.
PMID: 29289312
Communication and drug efficacy in the immune system rely heavily on diffusion of proteins such as cytokines through the tissue matrix. Available methods to analyze diffusion in tissue require microinjection...
5.
Tosoian J, Patel H, Mamawala M, Landis P, Wolf S, Elliott D, et al.
Prostate Cancer Prostatic Dis
. 2017 Apr;
20(3):339-342.
PMID: 28417979
Background: To assess the utility of urinary prostate cancer antigen 3 (PCA3) as both a one-time and longitudinal measure in men on active surveillance (AS). Methods: The Johns Hopkins AS...
6.
Tosoian J, Druskin S, Andreas D, Mullane P, Chappidi M, Joo S, et al.
Prostate Cancer Prostatic Dis
. 2017 Jan;
20(2):228-233.
PMID: 28117387
Background: The Prostate Health Index (phi) outperforms PSA and other PSA derivatives for the diagnosis of prostate cancer (PCa). The impact of phi testing in the real-world clinical setting has...
7.
Tse B, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, et al.
Oncogene
. 2017 Jan;
36(24):3417-3427.
PMID: 28092670
Recent evidence has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression. Primarily known as a regulator of neuronal guidance and angiogenesis, NRP1 is also expressed in multiple human malignancies,...
8.
Tosoian J, Alam R, Gergis C, Narang A, Radwan N, Robertson S, et al.
Prostate Cancer Prostatic Dis
. 2017 Jan;
20(2):193-196.
PMID: 28045113
Background: To evaluate the relationship between PSA testing history and high-risk disease among older men diagnosed with prostate cancer. Methods: Records from 1993 to 2014 were reviewed for men who...
9.
Benzon B, Zhao S, Haffner M, Takhar M, Erho N, Yousefi K, et al.
Prostate Cancer Prostatic Dis
. 2016 Nov;
20(1):28-35.
PMID: 27801901
Background: B7-H3 (CD276), part of the B7 superfamily of immune checkpoint molecules, has been shown to have an immunomodulatory role. Its regulation, receptor and mechanism of action remain unclear. B7-H3...
10.
Rowe S, Gorin M, Allaf M, Pienta K, Tran P, Pomper M, et al.
Prostate Cancer Prostatic Dis
. 2016 May;
19(3):223-30.
PMID: 27136743
Background: Prostate-specific membrane antigen (PSMA) is a cell surface enzyme that is highly expressed in prostate cancer (PCa) and is currently being extensively explored as a promising target for molecular...